Show channels:
All channels
Bladder cancer
Brain and spinal
Breast cancer
Cervical
Colon & rectal
Dermatological
General Information
Gynecological
Head and Neck
Kidney/adrenal
Liver
Lung
Lymphoma
Multiple Myeloma
Myelodysplastic syndromes
Myeloproliferative disorders
Pancreas
Pediatric
Prostate
Sarcoma
Stomach
Testicular
Thyroid
Upper aerodigestive
Found 15788 articles
HSPA4 upregulation induces immune evasion via ALKBH5/CD58 axis in gastric cancer
Histone acetylation causes HSPA4 upregulation in GC tumor tissues.
»
04/08/24
Clinical factors associated with patterns of endocrine therapy adherence in premenopausal breast cancer patients
Identified three adherence patterns among women—high adherers, slow decliners and rapid decliners.
»
04/08/24
Pembrolizumab-based first-line treatment for PD-L1-positive, recurrent or metastatic head and neck squamous cell carcinoma: a retrospective analysis
Patients with higher ECOG PS scores had worse PFS and OS.
»
04/08/24
MiR-380 inhibits the proliferation and invasion of cholangiocarcinoma cells by silencing LIS1
si-LIS1 salvaged promotive effect of miR-380 inhibitor.
»
04/06/24
Real-world patient characteristics and treatment patterns in US patients with advanced non-small cell lung cancer
Between 2016 and 2020, first-line treatment paradigm for advanced NSCLC in US shifted.
»
04/06/24
Use of circulating tumor cells and microemboli to predict diagnosis and prognosis in diffuse glioma.
Circulating tumor cell closely related to degree of malignancy.
»
04/12/24
Real-world evidence of treatment patterns and survival of metastatic gastric cancer patients in Germany
Systemic therapy not received in almost half of mGC patients.
»
04/13/24
Racial/ethnic differences in 21-gene recurrence score and survival among patients with estrogen receptor-positive breast cancer
Black women had worse OS.
»
04/13/24
Perioperative Immunotherapy for Node-Negative Non-Small Cell Lung Cancer - Current Evidence and Future Directions.
Emerging evidence now supports exploration of supplemental checkpoint blockade in well-selected early-stage patients.
»
12/19/23
PARP1 expression predicts PARP inhibitor sensitivity and correlates with metastatic potential and overall survival in melanoma.
High PARP1 levels correlate with worse overall survival of late stage metastasized melanoma patients.
»
03/20/24
< Prev
Next >